Back to PollNow

Back to companies

Evotec SE

EVODENASDAQPharmaceuticals & Healthcare

Evotec SE

Revenue

€797.0mn

YoY +2.0%

Operating income

-€142.5mn

FY2024

Employees

—

Founded

—

Source: U.S. Securities and Exchange Commission (SEC) EDGAR Company Facts API